Emergency Preparedness and Response

MCM Legal, Regulatory and Policy Framework

Stethoscope with booksThe FDA Medical Countermeasures Initiative (MCMi) legal, regulatory, and policy framework ensures that U.S. laws, regulations and policies help support preparedness and response for potential chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease threats. MCMi also helps facilitate advances in regulatory science available for practical use in the regulatory review process.

To do so, FDA assesses strengths and weaknesses of current medical countermeasure (MCM)-related development, distribution, administration, and use. We work with appropriate partners to develop and propose new approaches, where changes are needed to better protect public health.

Information in this Section


Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.

Page Last Updated: 04/26/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English